Fluoxetine and norfluoxetine are potent inhibitors of P450IID6‐the source of the sparteine/debrisoquine oxidation polymorphism [letter]

This publication has 18 references indexed in Scilit:

• Extremely Slow Metabolism of Amitriptyline but Normal Metabolism of Imipramine and Desipramine in an Extensive Metabolizer of Sparteine, Debrisoquine, and Mephenytoin
  Therapeutic Drug Monitoring, 1991
• Determination of imipramine and seven of its metabolites in human liver microsomes by a high-performance liquid chromatographic method
  Analytical Biochemistry, 1990
• Elevated antidepressant plasma levels after addition of fluoxetine
  American Journal of Psychiatry, 1989
• Fluoxetine Induces Elevation of Desipramine Level and Exacerbation of Geriatric Nonpsychotic Depression
  Journal of Clinical Psychopharmacology, 1988
• A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.
  Journal of Medical Genetics, 1980
• Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
  European Journal of Clinical Pharmacology, 1979